Portola Pharmaceuticals, Inc.

( )
PTLA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 2.57%58.766.5%$173.62m
CTLTCatalent, Inc. 3.40%76.242.1%$127.11m
VRXValeant Pharmaceuticals International, Inc. -4.83%17.5414.1%$103.21m
JAZZJazz Pharmaceuticals Plc -1.14%107.542.4%$96.91m
BHCBausch Health Cos., Inc. -4.83%17.540.0%$73.39m
UTHRUnited Therapeutics Corp. -0.69%117.7814.3%$69.53m
ICPTIntercept Pharmaceuticals, Inc. -2.91%44.0516.8%$60.95m
AXSMAxsome Therapeutics, Inc. 2.34%85.841.9%$53.99m
PCRXPacira Biosciences, Inc. 4.38%56.5410.3%$51.91m
ZGNXZogenix, Inc. 2.54%28.287.5%$49.40m
PRGOPerrigo Co. Plc -0.54%54.906.8%$48.11m
MYOKMyoKardia, Inc. 1.33%95.291.8%$46.96m
ARGXargenx SE 2.44%251.380.0%$42.46m
GWPHGW Pharmaceuticals Plc -0.48%129.006.2%$39.30m
AMRNAmarin Corp. Plc 0.45%6.771.6%$37.59m

Company Profile

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.